odel driven optimization of antiangiogenics plus cytotoxics combination: application to breast cancer mice treated with bevacizumab plus paclitaxel doublet leads to reduced tumor growth and fewer metastasis
XX
BSO - Titre
Model-driven optimization of antiangiogenics + cytotoxics combination: application to breast cancer mice treated with bevacizumab + paclitaxel doublet leads to reduced tumor growth and fewer metastasis
